Showing results (431-440 of 9,918) with videos related to
Sort By:
Pageof 992
Bone Marrow Transplantation|September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.Bone Marrow Transplantation|January 19, 2022
Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factorsHelene Jeppesen, Katrine Kielsen, Volkert Siersma, et al.Bone Marrow Transplantation|March 26, 2021
Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMTLoredana Ruggeri, Luca Vago, Diderik-Jan Eikema, et al.Bone Marrow Transplantation|March 6, 2021
Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMTAnnalisa Ruggeri, Myriam Labopin, Emanuele Angelucci, et al.Bone Marrow Transplantation|March 9, 2021
The evolving concept of indications for allogeneic hematopoietic cell transplantation during first complete remission of acute myeloid leukemiaMasamitsu YanadaBone Marrow Transplantation|November 4, 2022
High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumorsJunichi Hara, Kimikazu Matsumoto, Naoko Maeda, et al.Bone Marrow Transplantation|October 30, 2022
Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?Gabrielle Archer, Ingrid Berger, Louise Bondeelle, et al.Bone Marrow Transplantation|April 7, 2019
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.Bone Marrow Transplantation|April 7, 2019
Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomesMelhem M Solh, Elizabeth Dickhaus, Scott R Solomon, et al.Bone Marrow Transplantation|October 6, 2022
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myelomaCharalampos Charalampous, Utkarsh Goel, Morie Gertz, et al.Pageof 992